134 related articles for article (PubMed ID: 29755557)
1. Evaluation of Silibinin Effects on the Viability of HepG2 (Human hepatocellular liver carcinoma) and HUVEC (Human Umbilical Vein Endothelial) Cell Lines.
Vakili Zahir N; Nakhjavani M; Hajian P; Shirazi FH; Mirzaei H
Iran J Pharm Res; 2018; 17(1):261-267. PubMed ID: 29755557
[TBL] [Abstract][Full Text] [Related]
2. Silibinin efficacy against human hepatocellular carcinoma.
Varghese L; Agarwal C; Tyagi A; Singh RP; Agarwal R
Clin Cancer Res; 2005 Dec; 11(23):8441-8. PubMed ID: 16322307
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells.
Gu HR; Park SC; Choi SJ; Lee JC; Kim YC; Han CJ; Kim J; Yang KY; Kim YJ; Noh GY; No SH; Jeong JH
Clin Mol Hepatol; 2015 Mar; 21(1):49-59. PubMed ID: 25834802
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.
Tyagi A; Bhatia N; Condon MS; Bosland MC; Agarwal C; Agarwal R
Prostate; 2002 Nov; 53(3):211-7. PubMed ID: 12386921
[TBL] [Abstract][Full Text] [Related]
5. Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy.
Singh RP; Dhanalakshmi S; Agarwal C; Agarwal R
Oncogene; 2005 Feb; 24(7):1188-202. PubMed ID: 15558015
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of Silibinin combined with doxorubicin in hepatocellular carcinoma; an in vivo study.
Li WG; Wang HQ
J BUON; 2016; 21(4):917-924. PubMed ID: 27685914
[TBL] [Abstract][Full Text] [Related]
7. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R
Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
[TBL] [Abstract][Full Text] [Related]
8. Effects and mechanisms of silibinin on human hepatoma cell lines.
Lah JJ; Cui W; Hu KQ
World J Gastroenterol; 2007 Oct; 13(40):5299-305. PubMed ID: 17879397
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Co-Delivery Evaluation of Novel Pegylated Nano-Liposomal Herbal Drugs of Silibinin and Glycyrrhizic Acid (Nano-Phytosome) to Hepatocellular Carcinoma Cells.
Ochi MM; Amoabediny G; Rezayat SM; Akbarzadeh A; Ebrahimi B
Cell J; 2016; 18(2):135-48. PubMed ID: 27540518
[TBL] [Abstract][Full Text] [Related]
10. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
Tyagi AK; Agarwal C; Chan DC; Agarwal R
Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
[TBL] [Abstract][Full Text] [Related]
11. Trans Fatty Acids Suppress TNF-α-Induced Inflammatory Gene Expression in Endothelial (HUVEC) and Hepatocellular Carcinoma (HepG2) Cells.
Da Silva MS; Julien P; Bilodeau JF; Barbier O; Rudkowska I
Lipids; 2017 Apr; 52(4):315-325. PubMed ID: 28315997
[TBL] [Abstract][Full Text] [Related]
12. The apoptotic effects of silibinin on MDA-MB-231 and MCF-7 human breast carcinoma cells.
Bayram D; Çetin ES; Kara M; Özgöçmen M; Candan IA
Hum Exp Toxicol; 2017 Jun; 36(6):573-586. PubMed ID: 27402681
[TBL] [Abstract][Full Text] [Related]
13. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
Agarwal C; Singh RP; Dhanalakshmi S; Tyagi AK; Tecklenburg M; Sclafani RA; Agarwal R
Oncogene; 2003 Nov; 22(51):8271-82. PubMed ID: 14614451
[TBL] [Abstract][Full Text] [Related]
14. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
[TBL] [Abstract][Full Text] [Related]
15. Silibinin inhibits constitutive and TNFalpha-induced activation of NF-kappaB and sensitizes human prostate carcinoma DU145 cells to TNFalpha-induced apoptosis.
Dhanalakshmi S; Singh RP; Agarwal C; Agarwal R
Oncogene; 2002 Mar; 21(11):1759-67. PubMed ID: 11896607
[TBL] [Abstract][Full Text] [Related]
16. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages.
Tyagi A; Agarwal C; Harrison G; Glode LM; Agarwal R
Carcinogenesis; 2004 Sep; 25(9):1711-20. PubMed ID: 15117815
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of silibinin on the viability, migration and adhesion of the human prostate adenocarcinoma (PC-3) cell line.
Mokhtari MJ; Motamed N; Shokrgozar MA
Cell Biol Int; 2008 Aug; 32(8):888-92. PubMed ID: 18538589
[TBL] [Abstract][Full Text] [Related]
18. Effects of Cationic Microbubble Carrying CD/TK Double Suicide Gene and αVβ3 Integrin Antibody in Human Hepatocellular Carcinoma HepG2 Cells.
Li J; Zhou P; Li L; Zhang Y; Shao Y; Tang L; Tian S
PLoS One; 2016; 11(7):e0158592. PubMed ID: 27391603
[TBL] [Abstract][Full Text] [Related]
19.
Padmapriya R; Gayathri L; Ronsard L; Akbarsha MA; Raveendran R
Pharmacogn Mag; 2017 Jan; 13(Suppl 1):S16-S21. PubMed ID: 28479720
[TBL] [Abstract][Full Text] [Related]
20. Silibinin enhances ultraviolet B-induced apoptosis in mcf-7 human breast cancer cells.
Noh EM; Yi MS; Youn HJ; Lee BK; Lee YR; Han JH; Yu HN; Kim JS; Jung SH
J Breast Cancer; 2011 Mar; 14(1):8-13. PubMed ID: 21847388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
